Literature DB >> 14618615

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population.

Ana Osorio1, Raquel Rodríguez-López, Orland Díez, Miguel de la Hoya, José Ignacio Martínez, Ana Vega, Eva Esteban-Cardeñosa, Carmen Alonso, Trinidad Caldés, Javier Benítez.   

Abstract

Searching for low-penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this gene,1100delC, has been found to increase breast cancer susceptibility among familial breast cancer cases not attributable to mutations in BRCA1 or BRCA2 genes. In our present study, we evaluated the role of the 1100delC variant as a susceptibility allele in breast cancer in the Spanish population. However, our results suggest that this variant is absent or very infrequent in our population, making its screening irrelevant from the practical point of view. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14618615     DOI: 10.1002/ijc.11414

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Authors: 
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

Review 2.  Clinical implications of low-penetrance breast cancer susceptibility alleles.

Authors:  Francis Freisinger; Susan M Domchek
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

3.  CHEK2 c.1100delC mutation among non-BRCA1/2 Spanish hereditary breast cancer families.

Authors:  L Fachal; M Santamariña; A Blanco; A Carracedo; A Vega
Journal:  Clin Transl Oncol       Date:  2012-11-13       Impact factor: 3.405

4.  The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families.

Authors:  Ana Sánchez de Abajo; Miguel de la Hoya; Javier Godino; Vicente Furió; Alicia Tosar; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 5.  Breast cancer susceptibility: current knowledge and implications for genetic counselling.

Authors:  Tim Ripperger; Dorothea Gadzicki; Alfons Meindl; Brigitte Schlegelberger
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

6.  CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia.

Authors:  Eswary Thirthagiri; Leng San Cheong; Cheng Har Yip; Soo-Hwang Teo
Journal:  Fam Cancer       Date:  2009-04-28       Impact factor: 2.375

7.  Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer.

Authors:  Shaw-Hwa Lo; Herman Chernoff; Lei Cong; Yuejing Ding; Tian Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

8.  Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.

Authors:  Muhammad U Rashid; Noor Muhammad; Saima Faisal; Asim Amin; Ute Hamann
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

9.  CHEK2 contribution to hereditary breast cancer in non-BRCA families.

Authors:  Alexis Desrichard; Yannick Bidet; Nancy Uhrhammer; Yves-Jean Bignon
Journal:  Breast Cancer Res       Date:  2011-11-24       Impact factor: 6.466

10.  The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.

Authors:  Marielle W G Ruijs; Annegien Broeks; Fred H Menko; Margreet G E M Ausems; Anja Wagner; Rogier Oldenburg; Hanne Meijers-Heijboer; Laura J van't Veer; Senno Verhoef
Journal:  Hered Cancer Clin Pract       Date:  2009-02-17       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.